曲马多在膝骨关节炎中的应用:术前使用是否影响全膝关节置换术后的患者报告结局
这项回顾性研究分析了2017年1月至2018年3月接受单侧初次全膝关节置换术的患者,比较术前使用曲马多、使用麻醉药品与未使用麻醉药品三组患者的患者报告结局。术前KOOS评分三组无显著差异(P=0.60),术后3个月曲马多组KOOS改善最少(12.5分),事后分析中曲马多组与未用药组差异有统计学意义(P=0.016)。
要点
- 术前使用曲马多组术后3个月KOOS改善12.5分,少于未用药组的20.1分和麻醉药品组的19.1分,总体比较P=0.09。
- 事后分析中,术前使用曲马多组与未使用麻醉药品组术后3个月KOOS改善差异有统计学意义(P=0.016)。
- 三组术前KOOS评分无显著差异(未用药组50.4、曲马多组49.95、麻醉药品组48.01,P=0.60)。
核心结论
- 与术前未使用麻醉药品的患者相比,术前使用曲马多的患者术后短期功能结局改善趋势更少。
研究设计与样本
- 回顾性研究,分析前瞻性收集的2017年1月至2018年3月期间接受单侧初次全膝关节置换术患者的数据,共136例未使用麻醉药品、63例术前使用麻醉药品(其中21例使用曲马多)。
主要发现
- 术前KOOS评分:未用药组50.4、曲马多组49.95、麻醉药品组48.01(P=0.60)。
- 术后3个月KOOS改善:曲马多组平均12.5分,麻醉药品组19.1分,未用药组20.1分(P=0.09)。
- 事后分析中,未用药组与曲马多组术后3个月KOOS改善差异有统计学意义(P=0.016)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The 2013 American Academy of Orthopedic Surgeons evidence-based guidelines recommend against the use of preoperative narcotics in the management of symptomatic osteoarthritic knees; however, the guidelines strongly recommend tramadol in this patient population. To our knowledge, no study to date has evaluated outcomes in patients who use tramadol exclusively as compared with narcotics naive patients. METHODS: This is a retrospective study of prospectively collected data for patients who underwent unilateral primary total knee arthroplasty between January 2017 and March 2018. PRO scores were obtained using a novel electronic patient rehabilitation application, which pushed PRO surveys via email and mobile devices within 1 month prior to surgery and 3 months postoperatively. RESULTS: One hundred and thirty-six patients were opiate naïve, while 63 had obtained narcotics before the index operation. Of those, 21 patients received tramadol. The average preoperative Knee Disability and Osteoarthritis Outcome Scores were 50.4, 49.95, and 48.01 for the naïve, tramadol, and narcotic populations, respectively, (P = .60). The tramadol cohort had the least gain in 3 months postoperative Knee Disability and Osteoarthritis Outcome Scores, improving on average 12.5 points in comparison to the 19.1 and 20.1 improvements seen in the narcotic and naïve cohorts, respectively (P = .09). This difference was statistically significant when comparing the naïve and tramadol populations alone in post hoc analysis (P = .016). CONCLUSIONS: When comparing patients who took tramadol preoperatively to patients who were opiate naïve, patients that used tramadol trended toward significantly less improvement in functional outcomes in the short-term postoperative period.
引用
- Driesman A, Kaplan D, Feng JE, et al. Tramadol in Knee Osteoarthritis: Does Preoperative Use Affect Patient-Reported Outcomes After Total Knee Arthroplasty? J Arthroplasty. 2019. PMID: 31076193. doi:10.1016/j.arth.2019.03.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。